Topic: rheumatoid arthritis

abbvie

22. Rinvoq

The days without biosimilar competition are numbered for AbbVie’s Humira in the U.S.—and that’s where rheumatoid arthritis drug Rinvoq comes in.

15. Olumiant

Olumiant eventually nabbed the nod it needed to take on Pfizer’s Xeljanz, the only other drug in its class approved for rheumatoid arthritis, but with caveats.